ABSTRACT
Progress in biomedicine is strongly related to the complexity and accuracy of diagnostic techniques, as well as to the development of biomaterials. During the past decades, research in this eld has focused on biostable and biodegradable (hydrolytically and enzymatically degradable) compounds [1-6]. Among the available materials, polymers meet these criteria due to their functionality and ease of processing. Therefore, degradable polymeric biomaterials are often used in various biomedical elds, including pharmacology and tissue engineering. The latter represents a multidisciplinary domain involving application of knowledge in exact and life sciences in solving medical issues such as tissue loss and organ failure [7]. The main approach toward this direction consists in cell growth on bioactive degradable layers (scaffolds) that provide the physical and chemical indications to control their differentiation and assembly into 3D structures [8]. The success of tissue engineering lies in two main aspects: used biomaterials and fabrication technologies.
